Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 143 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)

NCT04925141

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
Locations
  • The Second People's Hospital of Shenzhen Shenzhen, Guangdong, China
  • Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Affiliated Zhongshan Hospital of Fudan University Shanghai, Shanghai Municipality, China
  • The First Affiliated Hospital, Medical College , Zhejiang University Hangzhou, Zhejiang, China
View Trial Details
Completed

Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia

NCT00012259

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +14 more
Locations
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Cedars-Sinai Comprehensive Cancer Center Los Angeles, California, United States
  • MD Anderson Cancer Center Orlando Orlando, Florida, United States
View all 20 locations
View Trial Details
Completed

Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential Thrombocythaemia

NCT01214915

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Akita University Hospital Akita, Japan
  • Juntendo University Hospital Hongo 3-1-3, Bunkyo-ku, Japan
  • Tokyo Metropolitan Cancer and Infectious diseases Center Kom Honkomagome 3-18-22, Bunkyo-ku, Japan
  • Nippon Medical School Hospital Sendagi 1-1-5, Bunkyo-ku, Japan
View all 19 locations
View Trial Details
Completed

Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia

NCT01467661

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Akita University Hospital Akita, Japan
  • Tokyo Metropolitan Cancer and Infectious diseases Center Kom Honkomagome 3-18-22, Bunkyo-ku, Japan
  • Nippon Medical School Hospital Sendagi 1-1-5, Bunkyo-ku, Japan
  • Chiba University Hospital Chuo-ku Inohana 1-8-1, Chiba-shi, Japan
View all 16 locations
View Trial Details
Completed

Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments

NCT00567502

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +6 more
Locations
  • Clinic of Haematology Limassol, Cyprus
  • Rigshospitalet Copenhagen, Denmark
  • SUS-Esbjerg Maematologisk afdelning Esbjerg, Denmark
  • Herlev Hospital Herlev, Denmark
View all 164 locations
View Trial Details
Completed

A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients

NCT00202644

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • University Multiprofile Hospital for Active Treatment ''Dr Georgi Stranski'' - Pleven Pleven, Bulgaria
  • University Multiprofile Hospital for active Treatment ''Alexandrovska'' Clinic of Haematology Sofia, Bulgaria
  • University Multiprofile Hospital for Active Treament ''Sv. Marina'' - Varna Haematology Clinic Varna, Bulgaria
  • CHU Angers Services des Maladies du Sang Angers, Cedex 09, France
View all 15 locations
View Trial Details
Completed

A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

NCT02130557

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +25 more
Locations
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View all 189 locations
View Trial Details

Related conditions